BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 7539473)

  • 21. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte and granulocyte-macrophage colony-stimulating factors exert differential effects on neutrophil platelet-activating factor generation and release.
    Stewart AG; Cotterill T; Harris T
    Immunology; 1994 May; 82(1):51-6. PubMed ID: 7519173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropenia.
    Hirashima K; Yoshida Y; Asano S; Takaku F; Omine M; Furusawa S; Abe T; Abe T; Dohy H; Tajiri M
    Biotherapy; 1991; 3(4):297-307. PubMed ID: 1723891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M; Kawanishi Y; Kuriyama K; Kuratsuji T; Toyama K
    Rinsho Ketsueki; 1990 Apr; 31(4):484-6. PubMed ID: 1696326
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective polymorphonuclear leukocyte functions in children receiving chemotherapy for cancer are partially restored by recombinant human granulocyte colony-stimulating factor in vitro.
    Lejeune M; Sariban E; Cantinieaux B; Ferster A; Devalck C; Fondu P
    J Infect Dis; 1996 Oct; 174(4):800-5. PubMed ID: 8843219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic neutropenia and defect in superoxide generation of granulocytes in two patients: enhancement of bactericidal capacity and respiratory burst activity by treatment with recombinant human granulocyte colony-stimulating factor.
    Káposzta R; Maródi L
    Pediatr Res; 1995 Jan; 37(1):50-5. PubMed ID: 7535420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of exogenous recombinant human granulocyte colony-stimulating factor (filgrastim, rhG-CSF) on neutrophils of critically ill patients with systemic inflammatory response syndrome depend on endogenous G-CSF plasma concentrations on admission.
    Weiss M; Voglic S; Harms-Schirra B; Lorenz I; Lasch B; Dumon K; Gross-Weege W; Schneider EM
    Intensive Care Med; 2003 Jun; 29(6):904-914. PubMed ID: 12682721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens.
    Gaviria JM; van Burik JA; Dale DC; Root RK; Liles WC
    J Infect Dis; 1999 Apr; 179(4):1038-41. PubMed ID: 10068606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methotrexate inhibits superoxide production and chemotaxis in neutrophils activated by granulocyte colony-stimulating factor.
    Okuda A; Kubota M; Sawada M; Koishi S; Kataoka A; Bessho R; Usami I; Lin YW; Adachi S; Furusho K
    J Cell Physiol; 1996 Jul; 168(1):183-7. PubMed ID: 8647914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum levels of endogenous and exogenous granulocyte colony-stimulating factor after autologous blood stem cell transplantation.
    Shimazaki C; Uchiyama H; Fujita N; Araki S; Sudo Y; Yamagata N; Ashihara E; Goto H; Inaba T; Haruyama H
    Exp Hematol; 1995 Dec; 23(14):1497-502. PubMed ID: 8542937
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody to capsular polysaccharide enhances the function of neutrophils from patients with AIDS against Cryptococcus neoformans.
    Monari C; Casadevall A; Retini C; Baldelli F; Bistoni F; Vecchiarelli A
    AIDS; 1999 Apr; 13(6):653-60. PubMed ID: 10397559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Response of human polymorphonuclear leukocytes and monocytes to Trichosporon beigelii: host defense against an emerging opportunistic pathogen.
    Lyman CA; Garrett KF; Pizzo PA; Walsh TJ
    J Infect Dis; 1994 Dec; 170(6):1557-65. PubMed ID: 7995996
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
    Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
    Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Superoxide production by neutrophils in children with malignant tumors treated with recombinant human granulocyte colony-stimulating factor.
    Iacobini M; Palumbo G; Bartolozzi S; Mondaini C; Castello M; Clerico A; Perla FM; Werner B; Digilio G
    Haematologica; 1995; 80(1):13-7. PubMed ID: 7538966
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophil oxidative burst in response to blastoconidia and pseudohyphae of Candida albicans: augmentation by granulocyte colony-stimulating factor and interferon-gamma.
    Roilides E; Uhlig K; Venzon D; Pizzo PA; Walsh TJ
    J Infect Dis; 1992 Sep; 166(3):668-73. PubMed ID: 1380052
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [In vivo effects on human neutrophils by administration of rhG-CSF and clinical significance].
    Okabe M; Saiki I; Nakane K; Miyazaki T
    Rinsho Byori; 1992 Apr; 40(4):397-402. PubMed ID: 1375667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of granulocyte colony-stimulating factor (G-CSF) treatment on granulocyte function and receptor expression in patients with ventilator-dependent pneumonia.
    Hustinx WN; Van Kessel CP; Heezius E; Burgers S; Lammers JW; Hoepelman IM
    Clin Exp Immunol; 1998 May; 112(2):334-40. PubMed ID: 9649199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peripheral blood neutrophils of germ-free rats modified by in vivo granulocyte-colony-stimulating factor and exposure to natural environment.
    Ohkubo T; Tsuda M; Suzuki S; El Borai N; Yamamura M
    Scand J Immunol; 1999 Jan; 49(1):73-7. PubMed ID: 10023860
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo administration of granulocyte-macrophage colony-stimulating factor and granulocyte colony-stimulating factor increases neutrophil oxidative burst activity.
    Wiltschke C; Krainer M; Nanut M; Wagner A; Linkesch W; Zielinski CC
    J Interferon Cytokine Res; 1995 Mar; 15(3):249-53. PubMed ID: 7584671
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Granulocyte-macrophage colony-stimulating factor enhances neutrophil function in acquired immunodeficiency syndrome patients.
    Baldwin GC; Gasson JC; Quan SG; Fleischmann J; Weisbart R; Oette D; Mitsuyasu RT; Golde DW
    Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2763-6. PubMed ID: 3282238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.